IDEXX is embedding proprietary AI into its core products, including analyzers (SediVue Dx, inVue Dx), decision support (DecisionIQ), and imaging software (Web PACS). This deep, cross-portfolio investment in AI is a key strategic differentiator requiring specialized talent and technology infrastructure.
Filing excerpt
Several of these point-of-care analyzers, including the Catalyst One Chemistry analyzer, ProCyte One hematology analyzer, SediVue Dx Analyzer, and IDEXX inVue Dx Cellular Analyzer, utilize proprietary AI capabilities in their image capture systems to analyze samples.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10kplatformStrategyGet every 10-K signal for Idexx Laboratories and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Idexx Laboratories this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/0e7adcca-fdb1-40c0-af85-6ad42503999f returns this record as JSON. POST /v1/companies/enrich returns every signal for idexx.com.
{
"signal_id": "0e7adcca-fdb1-40c0-af85-6ad42503999f",
"signal_type": "sec-10k",
"signal_subtype": "platformStrategy",
"detected_at": "2026-02-24T09:21:44.135+00:00",
"company": {
"name": "Idexx Laboratories",
"domain": "idexx.com"
},
"data": {
"detail": "IDEXX is embedding proprietary AI into its core products, including analyzers (SediVue Dx, inVue Dx), decision support (DecisionIQ), and imaging software (Web PACS). This deep, cross-portfolio investment in AI is a key strategic differentiator requiring specialized talent and technology infrastructure.",
"summary": "Investing heavily in AI capabilities across its diagnostic and software platforms",
"excerpts": "Several of these point-of-care analyzers, including the Catalyst One Chemistry analyzer, ProCyte One hematology analyzer, SediVue Dx Analyzer, and IDEXX inVue Dx Cellular Analyzer, utilize proprietary AI capabilities in their image capture systems to analyze samples.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Platform tools needed",
"signal_category": "strategic",
"technologies_mentioned": [
"AI",
"cloud"
]
}
}
curl https://signals.autobound.ai/v1/signals/0e7adcca-fdb1-40c0-af85-6ad42503999f \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"idexx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.